URGN
UroGenBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
URGN vs peer average
60/100
URGN vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
BCAX is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.29B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
URGN
UroGen
BCAX
Bicara Therapeutics
Grade
B
N/A
Momentum
92
61
Value
41
-
Sentiment
44
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Unrated
Grade position vs BCAX
URGN / BCAX
Grade Position
In line
URGN vs. peer average (B vs. C)
60/100
Momentum
92
URGNValue
41
-Sentiment
44
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs URGN
BCAX is the first peer returned for this comparison set.